Phathom Pharmaceuticals, Inc.PHATNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank86
3Y CAGR+22.1%
5Y CAGR+20.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+22.1%/yr
vs +244.1%/yr prior
5Y CAGR
+20.0%/yr
Consistent
Acceleration
-222.1pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.5x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $312.50M | -3.8% |
| 2024 | $324.75M | +93.5% |
| 2023 | $167.83M | -2.3% |
| 2022 | $171.82M | +27.7% |
| 2021 | $134.56M | +7.3% |
| 2020 | $125.36M | +18.0% |
| 2019 | $106.22M | +8570.6% |
| 2018 | $1.23M | - |